Work

The NOD2 agonist muramyl-di-peptide (MDP) reverses the inhibitory effects of TLR4 activation on enterocyte proliferation through effects on beta-catenin signaling, and attenuates the severity of experimental necrotizing enterocolitis

FWCI:
Cites:
Cited by:
Related to: 10